Related references
Note: Only part of the references are listed.Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
Shahab Asgharzadeh et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The role of aspirin in cancer prevention
Michael J. Thun et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Autocrine Prostaglandin E2 Signaling Promotes Tumor Cell Survival and Proliferation in Childhood Neuroblastoma
Agnes Rasmuson et al.
PLOS ONE (2012)
Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma
Agnes Rasmuson et al.
PLOS ONE (2012)
Thromboxane A2 receptor signaling promotes liver tissue repair after toxic injury through the enhancement of macrophage recruitment
Tsutomu Minamino et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Distinct signatures of the immune responses in low risk versus high risk neuroblastoma
Madhu Gowda et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Use of Aspirin and Other Nonsteroidal Antiinflammatory Medications in Relation to Prostate Cancer Risk
Claudia A. Salinas et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
David G. DeNardo et al.
CANCER AND METASTASIS REVIEWS (2010)
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
Suzanne Ostrand-Rosenberg
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells
Ofer Fainaru et al.
FASEB JOURNAL (2010)
Aspirin Intake and Survival After Breast Cancer
Michelle D. Holmes et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Embryonal neural tumours and cell death
John Inge Johnsen et al.
APOPTOSIS (2009)
CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages
David G. DeNardo et al.
CANCER CELL (2009)
Aspirin Use and Survival After Diagnosis of Colorectal Cancer
Andrew T. Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
V alpha 24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
Liping Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
FOXP3 Expression and Overall Survival in Breast Cancer
Andrea Merlo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
Bernard F. Cole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
Jack Cuzick et al.
LANCET ONCOLOGY (2009)
A Simple PCR Method for Rapid Genotype Analysis of the TH-MYCN Transgenic Mouse
Seiki Haraguchi et al.
PLOS ONE (2009)
Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3
Yung-Chi Chang et al.
BLOOD (2008)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
Histological profile of tumours from MYCN transgenic mice
H. C. Moore et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Tumour immunity: effector response to tumour and role of the microenvironment
Alberto Mantovani et al.
LANCET (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Macrophage polarization in tumour progression
Antonio Sica et al.
SEMINARS IN CANCER BIOLOGY (2008)
MYCN as a target for cancer immunotherapy
Nourredine Himoudi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Strong evidence for up-regulation of cyclooxygenase-1 in head and neck cancer
B. M. Erovic et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development
Caroline Aspord et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Aspirin activates the NF-κB signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer
Lesley A. Stark et al.
CARCINOGENESIS (2007)
P50 nuclear factor-κB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance
Alessandra Saccani et al.
CANCER RESEARCH (2006)
Pediatric cancers are infiltrated predominantly by macrophages and contain a paucity of dendritic cells: A major nosologic difference with adult tumors
J Vakkila et al.
CLINICAL CANCER RESEARCH (2006)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Mechanisms of embryonal tumor initiation:: Distinct roles for MycN expression and MYCN amplification
LM Hansford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo
JI Johnsen et al.
CANCER RESEARCH (2004)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
CD4(+) T cells in cancer stroma, not CD8(+) T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers
O Wakabayashi et al.
CANCER SCIENCE (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
N-myc oncogene overexpression down-regulates IL-6;: evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth
E Hatzi et al.
ONCOGENE (2002)